- Home
- NWFL vs DMAC Comparison
NWFL vs DMAC Comparison
Compare NWFL & DMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWFL
- DMAC
- Stock Information
- Founded
- NWFL 1870
- DMAC 2000
- Country
- NWFL United States
- DMAC United States
- Employees
- NWFL 265
- DMAC N/A
- Industry
- NWFL Major Banks
- DMAC Biotechnology: Pharmaceutical Preparations
- Sector
- NWFL Finance
- DMAC Health Care
- Exchange
- NWFL Nasdaq
- DMAC Nasdaq
- Market Cap
- NWFL 260.8M
- DMAC 185.1M
- IPO Year
- NWFL 1998
- DMAC N/A
- Fundamental
- Price
- NWFL $31.63
- DMAC $4.31
- Analyst Decision
- NWFL
- DMAC Strong Buy
- Analyst Count
- NWFL 0
- DMAC 3
- Target Price
- NWFL N/A
- DMAC $7.00
- AVG Volume (30 Days)
- NWFL 8.2K
- DMAC 33.4K
- Earning Date
- NWFL 10-28-2024
- DMAC 11-13-2024
- Dividend Yield
- NWFL 3.73%
- DMAC N/A
- EPS Growth
- NWFL N/A
- DMAC N/A
- EPS
- NWFL 1.59
- DMAC N/A
- Revenue
- NWFL $62,305,000.00
- DMAC N/A
- Revenue This Year
- NWFL N/A
- DMAC N/A
- Revenue Next Year
- NWFL N/A
- DMAC N/A
- P/E Ratio
- NWFL $20.24
- DMAC N/A
- Revenue Growth
- NWFL N/A
- DMAC N/A
- 52 Week Low
- NWFL $23.50
- DMAC $2.12
- 52 Week High
- NWFL $34.50
- DMAC $4.95
- Technical
- Relative Strength Index (RSI)
- NWFL 62.95
- DMAC 50.38
- Support Level
- NWFL $31.11
- DMAC $4.14
- Resistance Level
- NWFL $32.20
- DMAC $4.33
- Average True Range (ATR)
- NWFL 1.02
- DMAC 0.17
- MACD
- NWFL 0.32
- DMAC -0.02
- Stochastic Oscillator
- NWFL 61.22
- DMAC 60.47
About NWFL Norwood Financial Corp.
Norwood Financial Corp is a U.S.-based bank holding company. It offers various personal and business credit services, trust and investment products, and real estate settlement services to consumers, businesses, nonprofit organizations, and municipalities in each of the communities that the bank serves. The bank also manages automated teller machines at its branch location. It serves the Pennsylvanian counties of Wayne, Pike, Monroe, and Lackawanna, as well as Susquehanna County.
About DMAC DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.